![IJMS | Free Full-Text | Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study IJMS | Free Full-Text | Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study](https://pub.mdpi-res.com/ijms/ijms-18-01936/article_deploy/html/images/ijms-18-01936-g001.png?1569538250)
IJMS | Free Full-Text | Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study
![Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma - ScienceDirect Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S009286741831568X-fx1.jpg)
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma - ScienceDirect
![Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers](https://www.frontiersin.org/files/Articles/695006/fonc-11-695006-HTML/image_m/fonc-11-695006-g001.jpg)
Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
![Intratumoral CD8+ T cells with stem cell–like properties: Implications for cancer immunotherapy | Science Translational Medicine Intratumoral CD8+ T cells with stem cell–like properties: Implications for cancer immunotherapy | Science Translational Medicine](https://www.science.org/cms/asset/8d648695-d45b-4f31-9ba4-00a84f89e946/aay6863-f1.gif)
Intratumoral CD8+ T cells with stem cell–like properties: Implications for cancer immunotherapy | Science Translational Medicine
![Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer | British Journal of Cancer Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01514-7/MediaObjects/41416_2021_1514_Fig1_HTML.png)
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer | British Journal of Cancer
![Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis | Genome Biology | Full Text Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis | Genome Biology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13059-019-1921-y/MediaObjects/13059_2019_1921_Fig1_HTML.png)
Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis | Genome Biology | Full Text
![Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment | Cellular & Molecular Immunology Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcmi.2015.57/MediaObjects/41423_2015_Article_BFcmi201557_Fig1_HTML.jpg)
Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment | Cellular & Molecular Immunology
![The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma | npj Precision Oncology The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-020-00133-4/MediaObjects/41698_2020_133_Fig1_HTML.png)
The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma | npj Precision Oncology
![CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens: Molecular Therapy CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens: Molecular Therapy](https://www.cell.com/cms/attachment/cdadcbd3-67e1-45f4-92e3-783116a0b267/fx1_lrg.jpg)
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens: Molecular Therapy
![Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer | Science Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer | Science](https://www.science.org/cms/asset/94b743bb-f65b-4bb0-ad38-98fb4841d243/370_1328_f1.gif)
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer | Science
![Activation or exhaustion of CD8+ T cells in patients with COVID-19 | Cellular & Molecular Immunology Activation or exhaustion of CD8+ T cells in patients with COVID-19 | Cellular & Molecular Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41423-021-00750-4/MediaObjects/41423_2021_750_Fig1_HTML.png)
Activation or exhaustion of CD8+ T cells in patients with COVID-19 | Cellular & Molecular Immunology
![Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment | PNAS Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment | PNAS](https://www.pnas.org/cms/10.1073/pnas.1720948115/asset/ef939cc7-5d1d-402e-9be3-90fb4d4e53c4/assets/graphic/pnas.1720948115fig01.jpeg)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment | PNAS
![JCI Insight - Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer JCI Insight - Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer](https://df6sxcketz7bb.cloudfront.net/manuscripts/153000/153963/medium/jci.insight.153963.ga.jpg)
JCI Insight - Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer
![Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-018-05072-0/MediaObjects/41467_2018_5072_Fig1_HTML.jpg)
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications
![How to evaluate the immune status of lung cancer patients before immunotherapy | European Respiratory Society How to evaluate the immune status of lung cancer patients before immunotherapy | European Respiratory Society](https://breathe.ersjournals.com/content/breathe/13/4/291/F1.large.jpg?width=800&height=600&carousel=1)
How to evaluate the immune status of lung cancer patients before immunotherapy | European Respiratory Society
![PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/7/1/331/F1.large.jpg)